Antifibrotic Effects of Aldosterone Receptor Blocker (Spironolactone) in Patients with Chronic Kidney Disease

Author: Guney Ibrahim   Selcuk N. Yilmaz   Altintepe Lutfullah   Atalay Huseyin   Başarali M. Kemal   Büyükbaş Sadik  

Publisher: Informa Healthcare

ISSN: 0886-022X

Source: Renal Failure, Vol.31, Iss.9, 2009-10, pp. : 779-784

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content